Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Equity Ratio: 2010-2025

Historic Equity Ratio for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to 0.10.

  • ProPhase Labs' Equity Ratio fell 74.85% to 0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10, marking a year-over-year decrease of 74.85%. This contributed to the annual value of 0.12 for FY2024, which is 78.34% down from last year.
  • Per ProPhase Labs' latest filing, its Equity Ratio stood at 0.10 for Q3 2025, which was down 61.61% from 0.27 recorded in Q2 2025.
  • ProPhase Labs' Equity Ratio's 5-year high stood at 0.73 during Q4 2022, with a 5-year trough of 0.10 in Q3 2025.
  • Its 3-year average for Equity Ratio is 0.42, with a median of 0.47 in 2024.
  • Per our database at Business Quant, ProPhase Labs' Equity Ratio spiked by 95.33% in 2021 and then slumped by 78.34% in 2024.
  • Quarterly analysis of 5 years shows ProPhase Labs' Equity Ratio stood at 0.66 in 2021, then climbed by 10.57% to 0.73 in 2022, then declined by 26.00% to 0.54 in 2023, then plummeted by 78.34% to 0.12 in 2024, then slumped by 74.85% to 0.10 in 2025.
  • Its Equity Ratio stands at 0.10 for Q3 2025, versus 0.27 for Q2 2025 and 0.30 for Q1 2025.